¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"potential abnormality of glucose tolerance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • compound nerve action potential
    º¹ÇսŰæÈ°µ¿ÀüÀ§
  • cortical evoked potential
    °ÑÁúÀ¯¹ßÀüÀ§, ÇÇÁúÀ¯¹ßÀüÀ§
  • critical membrane potential
    ÀӰ踷ÀüÀ§
  • cutaneous nerve somatosensory evoked potential
    ÇǺνŰæ¸ö°¨°¢À¯¹ßÀüÀ§
  • demarcation potential
    ºÐ°èÀüÀ§
  • denervation potential
    Å»½Å°æÀüÀ§
  • diffusion potential
    È®»êÀüÀ§
  • disease potential
    Áúº´ÀáÀç·Â
  • evoked potential
    À¯¹ßÀüÀ§
  • excitatory junctional potential
    ÈïºÐÁ¢ÇÕºÎÀüÀ§
  • excitatory postsynaptic potential
    ÈïºÐ½Ã³À½ºÀÌÈÄÀüÀ§, ÈïºÐ¿¬Á¢ÀÌÈÄÀüÀ§
  • early receptor potential
    Á¶±â¼ö¿ëüÀüÀ§, Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
  • electric potential
    Àü±âÀüÀ§, ÀüÀ§
  • electric potential gradient
    ÀüÀ§±â¿ï±â
  • electrochemical potential
    Àü±âÈ­ÇÐÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • pharmacodynamic tolerance
    ¾à¿ªÇг»¼º
  • pressure tolerance
    ¾Ð¹Ú³»¼º
  • self-tolerance
    ÀÚ°¡°ü¿ë¼º
  • self tolerance
    ÀÚ±â¸é¿ªÇã¿ë
  • sitting tolerance
    ÁÂÀ§³»¼º, ¾ÉÀ½³»¼º
  • split tolerance
    ºÐÇҸ鿪Çã¿ë
  • tolerance
    ³»¼º, °ßµõ, Çã¿ë, °ü¿ë
  • thermal tolerance
    ¿­³»¼º
  • toxic tolerance
    µ¶¹°³»¼º
  • action potential
    Ȱµ¿ÀüÀ§
  • auditory evoked potential
    û°¢À¯¹ßÀüÀ§
  • biphasic action potential
    ÀÌ»óȰµ¿ÀüÀ§
  • brain stem evoked potential
    ³úÁÙ±âÀ¯¹ßÀüÀ§
  • potential barrier
    ÀüÀ§À庮
  • cognitive evoked potential
    ÀνÄÀ¯¹ßÀüÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • EPSP (excitatory postsynaptic potential)
    ÈïºÐ¼º(ýéÝÇàõ)½Ã³³½ºÈÄ(ý­)ÀüÀ§(ï³êÈ), ÈïºÐ¼º ¿¬Á¢(Ö§ïÈ)ÀüÀ§
  • Generator potential
    ±âµ¿ÀüÀ§(ÑÃÔÑï³êÈ)
  • IPSP = inhibitory postsynaptic potential
    ¾ïÁ¦¼º(åäð¤àõ)½Ã³À½ºÈÄ(ý­)Àü¾Ð(ï³äâ)
  • Intraneuronal potential
    ½Å°æ³»ÀüÀ§(ãêÌèÒ®ï³êÈ)
  • Junctional potential
    Á¢ÇÕºÎÀüÀ§(ïÈùêݬï³êÈ)
  • Local potential
    ±¹¼ÒÀüÀ§(ÏÑá¶ï³êÈ)
  • MEPP=>miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀü¾Ð
  • MEPP=£¾miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀüÀ§.
  • RP=£¾resting potential
    Á¤ÁöÀüÀ§.
  • Reinkes potential space
    ¶óÀÎÄÉ Àẹ°­
  • SEP, Somatosensory evoked potential
    ü¼º°¨°¢À¯¹ßÀüÀ§
  • absolute potential
    Àý´ëÀü¾Ð(¡­ï³äâ).³»°úÀý´ëÀüÀ§.
  • action potential
    Ȱµ¿ÀüÀ§(¡­ï³êÈ), Ȱµ¿Àü¾Ð(¡­ï³äâ)
  • alternating potential
    ±³·ù ÀüÀ§
  • generator potential
    ±âµ¿ÀüÀ§(ÑÃÔÑï³êÈ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • glucose fluctuation
    Æ÷µµ´çº¯µ¿
  • glucose intolerance
    Æ÷µµ´ç ºÒ³»¼º
  • glucose lactate cycle
    ±Û·çÄÚ¿À½º¶ôÆ®»ê ȸ·Î.
  • glucose level
    Æ÷µµ´çÄ¡<--ÁØÀ§>
  • glucose measurement
    Æ÷µµ´çÃøÁ¤
  • glucose monitoring
    Æ÷µµ´ç°¨½Ã
  • glucose oxidase
    Æ÷µµ´ç»êÈ­È¿¼Ò
  • glucose oxidase =GOD
    ±Û·çÄÚ¿À½º »êÈ­È¿¼Ò(¡­ß«ûùý£áÈ), ±Û·çÄÚ¿À½º¿Á½Ã ´ÙÁ¦.
  • glucose oxidizer
    Æ÷µµ´ç»êÈ­Á¦
  • glucose oxydase test
    Æ÷µµ´ç»êÈ­È¿¼Ò¹ý.
  • glucose oxydation fermentation test
    Æ÷µµ´ç»êÈ­¹ßÈ¿½ÃÇè.
  • glucose storage disease
    ´çÃàÀûÁúȯ.
  • glucose transport protein unit
    Æ÷µµ´ç ¿î¹Ý ´Ü¹é ´ÜÀ§(GLUT)
  • glucose-6-phosphatase
    ±Û·çÄÚ¿À½º-6-Æ÷½ºÆÄŸÁ¦
  • glucose-6-phosphate dehydrogenase
    ±Û·çÄÚ½º-6-ÀλêµðÇÏÀ̵å·ÎÀú³×À̽º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • junction potential
    Á¢ÇպΠÀüÀ§(ïÈùêÝ»ï³êÈ)
  • liquid junction potential
    ¾×üÁ¢Á¡ÀüÀ§(äûô÷ïÈïÇï³êÈ)
  • low-potential iron protein
    ÀúÀüÀ§ ö´Ü¹éÁú(î¸ï³êÈôÑÓ±ÛÜòõ)
  • membrane potential
    ¸·ÀüÀ§(دï³êÈ)
  • midpoint potential
    Áß°£Á¡ÀüÀ§(ñéÊàïÁï³êÈ)
  • operating potential
    ÀÛµ¿ÀüÀ§(íÂÔÑï³êÈ)
  • osmotic potential
    »ïÅõ´É(ß¶÷âÒö)
  • oxidation potential
    »êÈ­ ÀüÀ§(ß«ûùï³êÈ)
  • oxidation-reduction potential
    »êȭȯ¿ø ÀüÀ§(ß«ûùü½êªï³êÈ)
  • phosphate potential
    Àλê ÀüÀ§(×òß«ï³êÈ)
  • phosphate transfer potential
    ÀλêÀüÀÌ ÀüÀ§(×òß«ï®ì¹ï³êÈ)
  • phosphorylation potential
    ÀλêÈ­ ÀüÀ§(×òß«ûùï³êÈ)
  • phosphoryl transfer potential
    ÀλêÈ­ ÀüÀÌ ÀüÀ§(×òß«ûùï®ì¹ï³êÈ)
  • potential
    "ÀüÀ§(ï³êÈ), Æ÷ÅÙ¼È"
  • potential difference
    ÀüÀ§Â÷(ï³êÈó¬)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
COGTT cortisone oral glucose tolerance test
GITT gastrointestinal transit time; glucose insulin tolerance test
GLTT glucose-lactate tolerance test
GLU-5 five-hour glucose tolerance test
GTF glucose tolerance factor; glucosyl-transferase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
FSIVGTT frequently sampled intravenous glucose tolerance test
glucose 6-P glucose 6-phosphate
ETT Exercise Tolerance Test
FTQ Fagerstrom Tolerance Questionnaire
ITI Immune tolerance induction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dorsal root potential
    Èı٠Àü¾Ð
  • electric potential difference
    Àü¾Ð ÀüÀ§Â÷
  • electrical potential
    Àü±â·Â, ÀüÀ§
    1. Àü±âÀåÀ» ¸Å°³·Î ÇÏ¿© Á¤ÁöÇÑ ÀüÇÏ¿¡ ÀÛ¿ëÇÏ´Â Èû. 2. ¾î´À ÇÑ Á¡¿¡¼­ Àü±âÀû ÀÛ¿ëÀ» ¹ÌÄ¥ ¼ö ÀÖ´Â ¿¡³ÊÁöÀÇ ¾ç.
  • electrochemical potential
    Àü±â È­ÇÐ ÀüÀ§
  • electrode potential
    Àü±Ø Àü¾Ð
  • electromagnetic potential
    ÀüÀÚ ÀüÀ§
  • excitatory junctional potential
    ÈïºÐ¼º Á¢ÇպΠÀüÀ§
  • excitatory postsynaptic potential
    ÈïºÐ¼º ½Ã³³½º ÈÄ ÀüÀ§
    ¾Æ¼¼Æ¿Äݸ°À̳ª ±Û·çŸ¸ÞÀÌÆ®¿Í °°Àº ¹°Áú¿¡ Ȱ¼ºÈ­µÇ´Â ¾î¶² À̿ Åë·Î¸¦ ÅëÇØ ƯÁ¤ ÀÌ¿ÂÀÌ À¯ÀÔµÇ¾î ½Ã³À½º ÈO÷ÀÇ ¸·Àü¾ÐÀ» Å»ºÐ±Ø½Ã۰í, ±× °á°ú ¸·Àü¾ÐÀÌ ¿ªÄ¡¿¡ µµ´ÞÇÏ¿© ½Ã³À½ºÈÄ ¼¼Æ÷¿¡ Ȱµ¿ Àü¾ÐÀÌ »ý¼ºµÉ ¶§ ¿ªÄ¡¿¡ µµ´ÞÇϱ⠽±µµ·Ï ¸·Àü¾ÐÀ» Å»ºÐ±Ø½ÃŰ´Â Àü¾Ð.
  • fibrillation potential
    ¼¼µ¿ ÀüÀ§, Å»½Å°æ ÀüÀ§
  • inhibitory postsynaptic potential
    ¾ïÁ¦¼º ½Ã³³½ºÈÄ Àü¾Ð
    ¾ïÁ¦¼º ±¸½É·Î¿¡ ÀÏÁ¦È÷ Ãæµ¿ÀÌ °¡ÇØÁú ¶§ ½Ã³À½º ÈÄ ´º·Ð¿¡ ¹ßÇàÇÏ´Â ¸·ÀüÀ§ÀÇ Àϰú¼º °úºÐ±ØÀ̸ç, ÀÌ ¶§¹®¿¡ ½Å°æ ´ÜÀ§ÀÇ ¹ÝÀÀ¼ºÀÌ °¨¾àµÈ´Ù.
  • injury potential
    ¼Õ»ó ÀüÀ§
  • magnetic potential
    ÀÚ±â Æ÷ÅÙ¼È
  • normal potential
    Á¤»ó ÀüÀ§
  • oxidationreduction potential
    »êÈ­ ȯ¿ø ÀüÀ§
  • polarizing potential
    ºÐ±Ø Àü¾Ð
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
visual evoked potential Voltage fluctuations that may be recorded from the occipital area of the scalp as the result of retinal stimulation by a light flashing at 1/4-second intervals; commonly summated and averaged by computer.
(05 Mar 2000)
cell potential <cell biology, physiology> The voltage of an electrochemical cell, the larger the cell potential, the greater the extent of reaction when equilibrium is reached.
(26 Mar 1998)
resting potential <physiology> The electrical potential of the inside of a cell, relative to its surroundings. Almost all animal cells are negative inside, resting potentials are in the range 20 to 100mV, 70mV typical.
Resting potentials reflect the action of the sodium pump only indirectly, they are mainly caused by the subsequent diffusion of potassium out of the cell through potassium leak channels. The resting potential is thus close to the Nernst potential for potassium.
See: action potential.
(10 Mar 1998)
membrane potential <physiology> More correctly, transmembrane potential difference: the electrical potential difference across a plasma membrane.
See: resting potential, action potential.
(18 Nov 1997)
chemical potential <chemistry> The work required (in j mol 1) to bring a molecule from a standard state (usually infinitely separated in a vacuum) to a specified concentration.
More usually employed as chemical potential difference, the work required to bring one mole of a substance from a solution at one concentration to another at a different concentration, __ = RT.In (c2/cl). This definition is useful in studies of active transport, note that, for charged molecules, the electrical potential difference must also be considered (see electrochemical potential).
(18 Nov 1997)
miniature end plate potential <physiology> Small fluctuations (typically 0.5 mV) in the resting potential of postsynaptic cells.
They are the same shape as, but much smaller than, the end plate potentials caused by stimulation of the presynaptic cell. Miniature end plate potentials are considered as evidence for the quantal release of neurotransmitters at chemical synapses, a single miniature end plate potential resulting from the release of the contents of a single synaptic vesicle.
(12 Jan 1998)
water potential <plant biology> The chemical potential (i.e. Free energy per mole) of water in plants. Water moves within plants from regions of high water potential to regions of lower water potential, i.e. Down gradient.
(18 Nov 1997)
myogenic potential Action potential of muscle.
(05 Mar 2000)
postsynaptic potential In a synapse, a change in the resting potential of a postsynaptic cell following stimulation of the presynaptic cell. For example: in a cholinergic synapse, the release of acetylcholine from the presynaptic cell causes channels to open in the postsynaptic cell. Each channel opening causes a small depolarisation, known as a miniature end plate potential (mepp), these sum to produce an excitatory postsynaptic potential.
(18 Nov 1997)
potential Existing and ready for action but not yet active.
(18 Nov 1997)
potential energy <chemistry> Energy due to position, it is stored energy which can be used to do work.
(09 Jan 1998)
site potential tree A tree that has attained the average maximum height possible given site conditions where it occurs.
(05 Dec 1998)
somatosensory evoked potential The computer-averaged cortical and subcortical responses to repetitive stimulation of peripheral nerve sensory fibres.
(05 Mar 2000)
spike potential The main wave in the action potential of a nerve; it is followed by negative and positive afterpotentials.
(05 Mar 2000)
S potential Prolonged, slow, depolarising or hyperpolarising responses to illumination; initiated between the photoreceptor and ganglion cell layers of the retina.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á